Clinical streptococci and their sensitivity to enterocins produced by different strains of the species Enterococcus

Anna Kandricáková1, Andrea Lauková

  • 1Slovak Academy of Sciences, Institute of Animal Physiology, Košice, Slovakia.

Insights

This study explored enterocins (Ent) as a novel treatment for acute otitis media (AOM) in children. Enterocins showed antimicrobial activity against Streptococcus pneumoniae and Streptococcus pyogenes, suggesting a potential alternative to antibiotics.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Acute otitis media (AOM) is a common childhood infection caused by Streptococcus pneumoniae and Streptococcus pyogenes.
  • Antibiotic resistance in these pathogens necessitates the development of alternative treatments for AOM.

Purpose of the Study:

  • To investigate the in vitro sensitivity of Streptococcus pneumoniae and Streptococcus pyogenes isolated from AOM to enterocins.
  • To evaluate enterocins as a potential therapeutic agent against AOM-causing bacteria.

Main Methods:

  • In vitro testing of streptococci isolated from AOM against enterocins produced by Enterococcus faecium strains.
  • Determination of bacterial sensitivity and inhibition zones for various enterocins.

Main Results:

  • Streptococcus pneumoniae strains showed sensitivity to at least one enterocin, with one strain sensitive to five.
  • Streptococcus pyogenes strains demonstrated sensitivity to enterocins, with some inhibited by Enterocin A (P).
  • Most enterocins inhibited the growth of tested streptococci at concentrations between 100 and 3,200 AU/ml, with Streptococcus pyogenes being more sensitive than Streptococcus pneumoniae.

Conclusions:

  • Enterocins exhibit antimicrobial activity against key AOM pathogens, Streptococcus pneumoniae and Streptococcus pyogenes.
  • Enterocins represent a promising alternative or adjunct therapy for AOM, warranting further investigation.
  • The findings suggest a novel application for enterocins in combating antibiotic-resistant bacterial infections.

Related Concept Videos

Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
2.9K
Stringent Response in E. coli01:23

Stringent Response in E. coli

Bacterial growth is closely tied to nutrient availability, with cells proliferating exponentially under favorable conditions and entering a stationary phase when resources become scarce. This transition is mediated by a regulatory mechanism known as the stringent response, which allows bacteria to adapt to nutrient deprivation by modulating gene expression and metabolic activity.During nutrient scarcity, intracellular amino acid levels decline. It results in the accumulation of uncharged tRNAs...
526
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
138
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid...
88
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
215
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90